课题基金 / 基金详情

COMPARE ANTIVIRAL EFFICACY OF ORALTDF & SUBCUTANEOUSTFV IN SIV-INFECTED MACAQUES

COMPARE ANTIVIRAL EFFICACY OF ORALTDF & SUBCUTANEOUSTFV IN SIV-INFECTED MACAQUES
比较 ORALTDF 的抗病毒功效
批准号:
7959077
负责人:
KOEN K VAN ROMPAY
金额:
$14.66万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2010-04-30

项目摘要

项目成果

KOEN K VAN ROMPAY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The study will compare the antiviral efficacy and pharmacokinetics of the parenteral compound tenofovir and its prodrug tenofovir disoproxyl fumarate in groups of SIV-infected macaques.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques
  • 批准号:
    10223632
  • 项目类别:
  • 资助金额:
    $88.69万
  • 财政年份:
    2020
  • 负责人:
    KOEN K VAN ROMPAY
  • 依托单位:
Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques
COMPARE ANTIVIRAL EFFICACY OF ORALTDF & SUBCUTANEOUSTFV IN SIV-INFECTED MACAQUES
  • 批准号:
    8357301
  • 项目类别:
  • 资助金额:
    $19.14万
  • 财政年份:
    2011
  • 负责人:
    KOEN K VAN ROMPAY
  • 依托单位:
LONG-TERM SAFETY AND EFFICACY OF PMPA (TENOFOVIR)
  • 批准号:
    8357237
  • 项目类别:
  • 资助金额:
    $19.14万
  • 财政年份:
    2011
  • 负责人:
    KOEN K VAN ROMPAY
  • 依托单位:
海外基金